In Round 1, Queensland Genomics overarching logic and design was based on:
The conduct of a series of Clinical Demonstration Projects over three 18-month funding rounds;
The concurrent establishment of five Capability-building Workstreams over three 18-month phases; and
A clinically-led and patient-centred translational research and implementation focus.
The Round 1 granting process occurred in late 2016, with successful projects awarded in April 2017. Round 1 clinical and capability projects began in September 2017, and are due for completion by March 2019.
The Round 2 investment decision making process occurred in 2018, with successful projects announced in early 2019.